ID   L1210/PtR4
AC   CVCL_4V14
SY   L1210 PtR4; L1210PtR4; L1210 (PtR4); L1210(PTR4)
DR   ChEMBL-Cells; CHEMBL3307416
DR   ChEMBL-Targets; CHEMBL614711
DR   PubChem_Cell_line; CVCL_4V14
DR   Wikidata; Q54900963
RX   PubMed=3335002;
CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 05-10-23; Version: 11
//
RX   PubMed=3335002;
RA   Kraker A.J., Moore C.W.;
RT   "Accumulation of cis-diamminedichloroplatinum(II) and platinum
RT   analogues by platinum-resistant murine leukemia cells in vitro.";
RL   Cancer Res. 48:9-13(1988).
//